SG11202001010UA - Methods and materials for assessing and treating cancer - Google Patents

Methods and materials for assessing and treating cancer

Info

Publication number
SG11202001010UA
SG11202001010UA SG11202001010UA SG11202001010UA SG11202001010UA SG 11202001010U A SG11202001010U A SG 11202001010UA SG 11202001010U A SG11202001010U A SG 11202001010UA SG 11202001010U A SG11202001010U A SG 11202001010UA SG 11202001010U A SG11202001010U A SG 11202001010UA
Authority
SG
Singapore
Prior art keywords
assessing
materials
methods
treating cancer
cancer
Prior art date
Application number
SG11202001010UA
Inventor
Bert Vogelstein
Kenneth W Kinzler
Joshua Cohen
Nickolas Papadopoulos
Anne Marie Lennon
Cristian Tomasetti
Yuxuan Wang
Georges Jabboure Netto
Rachel Karchin
Chris Douville
Samir Hanash
Simeon Springer
Arthur Grollman
Kathleen Dickman
Original Assignee
Univ Johns Hopkins
Board Of Regents The University Of Texas Systems
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201762542164P priority Critical
Priority to US201762542144P priority
Priority to US201762542167P priority
Priority to US201762594245P priority
Priority to US201862618232P priority
Priority to US201862628759P priority
Priority to US201862629870P priority
Application filed by Univ Johns Hopkins, Board Of Regents The University Of Texas Systems, Univ New York State Res Found filed Critical Univ Johns Hopkins
Priority to PCT/US2018/045669 priority patent/WO2019067092A1/en
Publication of SG11202001010UA publication Critical patent/SG11202001010UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/30Detection characterised by liberation or release of label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/50Detection characterised by immobilisation to a surface
    • C12Q2565/514Detection characterised by immobilisation to a surface characterised by the use of the arrayed oligonucleotides as identifier tags, e.g. universal addressable array, anti-tag or tag complement array
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60Detection means characterised by use of a special device
    • C12Q2565/625Detection means characterised by use of a special device being a nucleic acid test strip device, e.g. dipsticks, strips, tapes, CD plates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis
SG11202001010UA 2017-08-07 2018-08-07 Methods and materials for assessing and treating cancer SG11202001010UA (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US201762542164P true 2017-08-07 2017-08-07
US201762542144P true 2017-08-07 2017-08-07
US201762542167P true 2017-08-07 2017-08-07
US201762594245P true 2017-12-04 2017-12-04
US201862618232P true 2018-01-17 2018-01-17
US201862628759P true 2018-02-09 2018-02-09
US201862629870P true 2018-02-13 2018-02-13
PCT/US2018/045669 WO2019067092A1 (en) 2017-08-07 2018-08-07 Methods and materials for assessing and treating cancer

Publications (1)

Publication Number Publication Date
SG11202001010UA true SG11202001010UA (en) 2020-03-30

Family

ID=63678664

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001010UA SG11202001010UA (en) 2017-08-07 2018-08-07 Methods and materials for assessing and treating cancer

Country Status (12)

Country Link
US (2) US20200377956A1 (en)
EP (2) EP3665308A1 (en)
JP (1) JP2020530290A (en)
KR (1) KR20200115450A (en)
CN (1) CN111868260A (en)
AU (1) AU2018342007A1 (en)
BR (1) BR112020002555A2 (en)
CA (1) CA3072195A1 (en)
CL (1) CL2020000343A1 (en)
IL (1) IL272470D0 (en)
SG (1) SG11202001010UA (en)
WO (2) WO2019067092A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2577828A (en) 2017-06-13 2020-04-08 Bostongene Corp Systems and methods for identifying cancer treatments from normalized biomarker scores
CA3072195A1 (en) * 2017-08-07 2019-04-04 The Johns Hopkins University Methods and materials for assessing and treating cancer
WO2019195769A1 (en) * 2018-04-06 2019-10-10 The Brigham And Women's Hospital, Inc. Methods of diagnosing and treating aggressive cutaneous t-cell lymphomas
US20210313011A1 (en) * 2018-10-17 2021-10-07 Quest Diagnostics Investments Llc Genomic sequencing selection system
WO2020176620A1 (en) * 2019-02-26 2020-09-03 Tempus Systems and methods for using sequencing data for pathogen detection
WO2020219463A1 (en) * 2019-04-22 2020-10-29 Orbit Genomics, Inc. Methods and systems for microsatellite analysis
TW202108774A (en) * 2019-05-13 2021-03-01 美商格瑞爾公司 Model-based featurization and classification
WO2020232359A1 (en) * 2019-05-15 2020-11-19 The Regents Of The University Of California Methods concerning ongoing treatment for cancer
WO2020236625A2 (en) * 2019-05-17 2020-11-26 The Johns Hopkins University Rapid aneuploidy detection
WO2020243442A1 (en) * 2019-05-31 2020-12-03 Qed Therapeutics, Inc. Methods of treating urinary system cancers
US11036610B2 (en) 2019-05-31 2021-06-15 Apple Inc. Logging techniques for third party application data
US20210010061A1 (en) * 2019-07-01 2021-01-14 Mission Bio, Inc. Method and apparatus to normalize quantitative readouts in single-cell experiments
WO2021013805A1 (en) * 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag Systems and methods for cell of origin determination from variant calling data
WO2021042066A1 (en) * 2019-08-30 2021-03-04 Foundation Medicine, Inc. Kmt2a-maml2 fusion molecules and uses thereof
WO2021042131A1 (en) * 2019-08-30 2021-03-04 Life Technologies Corporation Compositions and methods for oncology precision assays
WO2021046655A1 (en) * 2019-09-13 2021-03-18 University Health Network Detection of circulating tumor dna using double stranded hybrid capture
CN113227401A (en) * 2019-10-08 2021-08-06 Illumina公司 Fragment size characterization of cell-free DNA mutations from clonal hematopoiesis
WO2021070039A2 (en) * 2019-10-09 2021-04-15 Immunitybio, Inc. Detecting homologous recombination deficiencies (hrd) in clinical samples
WO2021077094A1 (en) * 2019-10-18 2021-04-22 The Regents Of The University Of California Discovering, validating, and personalizing transposable element cancer vaccines
WO2021092331A1 (en) * 2019-11-06 2021-05-14 Ohio State Innovation Foundation Targeting circular pcmtd1 in leukemias with p53 mutations and/or bcr/abl fusions
WO2021097252A1 (en) * 2019-11-13 2021-05-20 Bradley Bernstein Methylation assays and uses thereof
WO2021126896A1 (en) * 2019-12-16 2021-06-24 Ohio State Innovation Foundation Next-generation sequencing diagnostic platform and related methods
US20210217486A1 (en) * 2020-01-10 2021-07-15 The Joan and Irwin Jacobs Technion-Cornell Institute Method for monitoring and management of cell lines using periodic low-coverage dna sequencing data
WO2021142437A1 (en) * 2020-01-10 2021-07-15 Gritstone Bio, Inc. Cell-free dna monitoring
CN111190013B (en) * 2020-02-27 2020-09-08 郑州大学第一附属医院 Group of esophageal cancer detection markers and application thereof in preparation of esophageal cancer screening kit
WO2021195131A1 (en) * 2020-03-23 2021-09-30 Fusion Pharmaceuticals Inc. Fgfr3-targeted radioimmunoconjugates and uses thereof
CN112011611B (en) * 2020-05-25 2021-04-23 桂林医学院附属医院 Application of circRNA in diagnosis and treatment of gastric cancer
CN113436677A (en) * 2021-08-13 2021-09-24 北京大学 System and method for testing possibility of liver cancer of subject

Family Cites Families (203)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040166A (en) 1985-03-28 2000-03-21 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences, including a probe
GB9323305D0 (en) 1993-11-11 1994-01-05 Medinnova Sf Isoaltion of nucleic acid
US6027890A (en) 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
US6361940B1 (en) 1996-09-24 2002-03-26 Qiagen Genomics, Inc. Compositions and methods for enhancing hybridization and priming specificity
EP1000175A1 (en) 1997-07-22 2000-05-17 Rapigene, Inc. Amplification and other enzymatic reactions performed on nucleic acid arrays
DE19813317A1 (en) 1998-03-26 1999-09-30 Roche Diagnostics Gmbh Nucleic acid amplification involving primer extension preamplification, especially for whole genome amplification
US6576420B1 (en) 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
EP1090293B2 (en) 1998-06-24 2019-01-23 Illumina, Inc. Decoding of array sensors with microspheres
US7510841B2 (en) 1998-12-28 2009-03-31 Illumina, Inc. Methods of making and using composite arrays for the detection of a plurality of target analytes
US7683035B1 (en) 1999-02-23 2010-03-23 Qiagen, Gmbh Method of stabilizing and/or isolating nucleic acids
US20060275782A1 (en) 1999-04-20 2006-12-07 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US6544732B1 (en) 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
EP2360270B1 (en) 1999-05-20 2016-11-09 Illumina, Inc. Combinatorial decoding of random nucleic acid arrays
AU2246601A (en) 1999-08-30 2001-04-10 Illumina, Inc. Methods for improving signal detection from an array
WO2001023618A2 (en) 1999-09-30 2001-04-05 Qiagen Genomics, Inc. Compositions and methods for reducing oligonucleotide hybridization and priming specificity
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
DE10031236A1 (en) 2000-06-27 2002-01-10 Qiagen Gmbh Use of carboxylic acids and other additives in combination with cationic compounds to stabilize nucleic acids in biological materials
CA2411794A1 (en) 2000-06-30 2002-01-10 Molecular Staging, Inc. Signal amplification with lollipop probes
EP1379995A2 (en) 2000-08-09 2004-01-14 Illumina, Inc. Automated information processing in randomly ordered arrays
AU8839301A (en) 2000-08-25 2002-03-04 Illumina Inc Probes and decoder oligonucleotides
AU2002326290A1 (en) 2001-03-01 2002-12-16 Illumina, Inc. Methods for improving signal detection from an array
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US7499806B2 (en) 2002-02-14 2009-03-03 Illumina, Inc. Image processing in microsphere arrays
US20040259105A1 (en) 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US6977153B2 (en) 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
US8150626B2 (en) 2003-05-15 2012-04-03 Illumina, Inc. Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns
EP1636337A4 (en) 2003-06-20 2007-07-04 Illumina Inc Methods and compositions for whole genome amplification and genotyping
US7745125B2 (en) 2004-06-28 2010-06-29 Roche Molecular Systems, Inc. 2′-terminator related pyrophosphorolysis activated polymerization
JP2007512020A (en) 2003-11-26 2007-05-17 エッペンドルフ アクチェンゲゼルシャフト Methods and compositions for in vitro amplification of extrachromosomal nucleic acids
EP2275534A1 (en) 2003-12-02 2011-01-19 Institut Pasteur Novel strain of sars-associated coronavirus and applications thereof
US7776531B1 (en) 2004-03-25 2010-08-17 Illumina, Inc. Compositions and methods for stabilizing surface bound probes
KR20070004957A (en) 2004-04-20 2007-01-09 제나코 바이오메디컬 프로덕츠, 인코포레이티드 Method for detecting ncrna
JP5149622B2 (en) 2004-05-20 2013-02-20 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド Single label comparative hybridization
US7323310B2 (en) 2004-08-31 2008-01-29 Qiagen North American Holdings, Inc. Methods and compositions for RNA amplification and detection using an RNA-dependent RNA-polymerase
US20090088328A1 (en) 2004-11-23 2009-04-02 Quest Diagnostics Investments Incorporated Microarray Quality Control
US20060127918A1 (en) 2004-12-14 2006-06-15 Quest Diagnostics Investments Incorporated Nucleic acid arrays
EP1846760B1 (en) 2005-01-27 2010-12-15 Quest Diagnostics Investments Incorporated Rapid comparative genome hybridization
DE602005009324D1 (en) 2005-04-06 2008-10-09 Maurice Stroun Method for cancer diagnosis by detection of DNA and RNA in the circulation
SG2014011837A (en) 2005-04-18 2014-04-28 Mitomics Inc Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
US20060292576A1 (en) 2005-06-23 2006-12-28 Quest Diagnostics Investments Incorporated Non-in situ hybridization method for detecting chromosomal abnormalities
US7977108B2 (en) 2005-07-25 2011-07-12 Roche Molecular Systems, Inc. Method for detecting a mutation in a repetitive nucleic acid sequence
KR101515821B1 (en) 2005-09-01 2015-04-30 오스다이어그나스틱스 피티와이 엘티디. Methods for the amplification, quantitation and identification of nucleic acids
US8076074B2 (en) 2005-11-29 2011-12-13 Quest Diagnostics Investments Incorporated Balanced translocation in comparative hybridization
EP2076609A1 (en) 2006-10-10 2009-07-08 Illumina Inc. Compositions and methods for representational selection of nucleic acids fro complex mixtures using hybridization
DE102006050037A1 (en) 2006-10-24 2008-04-30 Robert Bosch Gmbh Ultrasonic transducer for motor vehicle, has damping unit for damping vibrations of wall, arranged in diaphragm pot in edge section of diaphragm and connected with edge section and inner side of wall in force-fitting manner
US7899626B2 (en) 2007-01-10 2011-03-01 Illumina, Inc. System and method of measuring methylation of nucleic acids
DE102007016707A1 (en) 2007-04-04 2008-10-09 Qiagen Gmbh Process for the purification of biomolecules
US8999634B2 (en) 2007-04-27 2015-04-07 Quest Diagnostics Investments Incorporated Nucleic acid detection combining amplification with fragmentation
DE102007025277A1 (en) 2007-05-31 2008-12-04 Qiagen Gmbh Method for stabilizing a biological sample
US7507539B2 (en) 2007-07-30 2009-03-24 Quest Diagnostics Investments Incorporated Substractive single label comparative hybridization
US8871687B2 (en) 2007-09-28 2014-10-28 Quest Diagnostics Investments Incorporated Nucleic acid sequencing by single-base primer extension
EP2053132A1 (en) 2007-10-23 2009-04-29 Roche Diagnostics GmbH Enrichment and sequence analysis of geomic regions
US8093063B2 (en) 2007-11-29 2012-01-10 Quest Diagnostics Investments Incorporated Assay for detecting genetic abnormalities in genomic nucleic acids
US20090298187A1 (en) 2008-04-17 2009-12-03 Qiagen Gaithersburg, Inc. Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
EP2283132B1 (en) 2008-05-02 2016-10-26 Epicentre Technologies Corporation Selective 5' ligation tagging of rna
US9410956B1 (en) 2008-08-01 2016-08-09 University Of South Florida Micro-RNA profiling in ovarian cancer
CA2736124A1 (en) * 2008-09-03 2010-03-11 The Johns Hopkins University Pathways underlying pancreatic tumorigenesis and an hereditary pancreatic cancer gene
WO2010062556A1 (en) 2008-10-27 2010-06-03 Qiagen Gaithersburg Inc. Fast results hybrid capture assay and system
WO2010056499A1 (en) 2008-10-30 2010-05-20 Qiagen Gmbh Individually synthesized primers to be used in whole genome amplification
US8399221B2 (en) 2008-11-04 2013-03-19 Sabiosciences Corporation Methods for detection and quantitation of small RNAs
WO2010055487A2 (en) 2008-11-13 2010-05-20 Koninklijke Philips Electronics N.V. Compositions and methods for micro-rna expession profiling of colorectal cancer
EP2193831A1 (en) 2008-12-05 2010-06-09 Qiagen GmbH Parallel extraction of different biomolecules made of Formalin-fixed tissue
WO2010088273A1 (en) 2009-01-27 2010-08-05 Qiagen Gaithersburg Thermophilic helicase dependent amplification technology with endpoint homogenous fluorescent detection
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
WO2010099230A2 (en) 2009-02-25 2010-09-02 Illumina, Inc. Separation of pyrophosphate release and pyrophosphate detection
US9347092B2 (en) 2009-02-25 2016-05-24 Roche Molecular System, Inc. Solid support for high-throughput nucleic acid analysis
JP5457222B2 (en) 2009-02-25 2014-04-02 エフ.ホフマン−ラ ロシュ アーゲー Miniaturized high-throughput nucleic acid analysis
WO2010117620A2 (en) 2009-03-30 2010-10-14 Illumina, Inc. Gene expression analysis in single cells
EP2425019B1 (en) 2009-05-01 2014-03-19 QIAGEN Gaithersburg, Inc. A non-target amplification method for detection of rna splice-forms in a sample
EP2435584B1 (en) 2009-05-26 2016-07-13 Quest Diagnostics Investments Incorporated Methods for detecting gene dysregulations
EP2438197B1 (en) * 2009-06-05 2015-07-15 Myriad Genetics, Inc. Methods of detecting cancer
US8409802B2 (en) 2009-08-14 2013-04-02 Roche Molecular Systems, Inc. Format of probes to detect nucleic acid differences
WO2011050981A2 (en) 2009-10-30 2011-05-05 Roche Diagnostics Gmbh Method for detecting balanced chromosomal aberrations in a genome
EP2510126B1 (en) 2009-12-07 2017-08-09 Illumina, Inc. Multi-sample indexing for multiplex genotyping
US9238832B2 (en) 2009-12-11 2016-01-19 Roche Molecular Systems, Inc. Allele-specific amplification of nucleic acids
CA2785999C (en) 2009-12-14 2021-04-13 North Carolina State University Mean dna copy number of chromosomal regions is of prognostic significance in cancer
CN102822189B (en) 2010-01-29 2016-06-29 奇亚根盖瑟斯堡股份有限公司 The method and composition of (multiplex analysis) is analyzed for the sequence-specific purification of nucleic acid and MULTIPLE COMPOSITE body
US8951940B2 (en) 2010-04-01 2015-02-10 Illumina, Inc. Solid-phase clonal amplification and related methods
US20130059741A1 (en) 2010-05-13 2013-03-07 Illumina, Inc. Binding assays for markers
CA2799200A1 (en) 2010-05-19 2011-11-24 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
WO2012034130A2 (en) 2010-09-10 2012-03-15 Qiagen Methods and compositions for nucleic acid detection
US8483969B2 (en) 2010-09-17 2013-07-09 Illuminia, Inc. Variation analysis for multiple templates on a solid support
WO2012047899A2 (en) 2010-10-04 2012-04-12 The Johns Hopkins University Novel dna hypermethylation diagnostic biomarkers for colorectal cancer
DK3214091T3 (en) 2010-12-09 2019-01-07 Univ Pennsylvania USE OF CHEMICAL ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF CANCER
WO2012082841A2 (en) 2010-12-14 2012-06-21 University Of Maryland, Baltimore Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
EP2659005A4 (en) 2010-12-28 2016-08-24 Caris Mpi Inc Molecular profiling for cancer
KR20190100425A (en) 2010-12-30 2019-08-28 파운데이션 메디신 인코포레이티드 Optimization of multigene analysis of tumor samples
EP2663652B1 (en) 2011-01-11 2018-11-14 Roche Diagniostics GmbH High resolution melting analysis as a prescreening tool
US9365897B2 (en) 2011-02-08 2016-06-14 Illumina, Inc. Selective enrichment of nucleic acids
US8728732B2 (en) 2011-03-01 2014-05-20 The Johns Hopkins University Global DNA hypomethylation and biomarkers for clinical indications in cancer
ES2472965T3 (en) 2011-03-04 2014-07-03 F. Hoffmann-La Roche Ag New type of universal probes for the detection of genomic variants
US8658572B2 (en) 2011-03-18 2014-02-25 Roche Nimblegen, Inc. Whole proteome tiling microarrays
ES2625288T3 (en) 2011-04-15 2017-07-19 The Johns Hopkins University Secure Sequencing System
CA2838736A1 (en) 2011-06-07 2012-12-13 Caris Mpi, Inc. Molecular profiling for cancer
ES2752653T3 (en) 2011-09-23 2020-04-06 Illumina Inc Methods and compositions for nucleic acid sequencing
US9410206B2 (en) 2011-11-30 2016-08-09 John Wayne Cancer Institute Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer
EP2809801B1 (en) * 2012-01-31 2018-07-25 Speiser, Paul Non-invasive cancer diagnosis
CA2865163A1 (en) 2012-02-23 2013-08-29 Qiagen Mansfield, Inc. Multimodal pcr target detection
CN111073962A (en) 2012-03-26 2020-04-28 约翰霍普金斯大学 Rapid aneuploidy detection
EP2653558B1 (en) 2012-04-18 2015-10-07 Roche Diagniostics GmbH A method of detecting nucleic acid targets using a statistical classifier
EP3428290A1 (en) 2012-07-26 2019-01-16 Illumina, Inc. Compositions and methods for the amplification of nucleic acids
US20150197787A1 (en) 2012-08-02 2015-07-16 Qiagen Gmbh Recombinase mediated targeted dna enrichment for next generation sequencing
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
WO2014044724A1 (en) 2012-09-18 2014-03-27 Qiagen Gmbh Method and kit for preparing a target rna depleted sample
US20140128270A1 (en) 2012-11-08 2014-05-08 Roche Molecular Systems, Inc. Method of improving microarray performance by strand elimination
US9218450B2 (en) 2012-11-29 2015-12-22 Roche Molecular Systems, Inc. Accurate and fast mapping of reads to genome
EP2929350A4 (en) 2012-12-04 2016-11-16 Caris Mpi Inc Molecular profiling for cancer
US9382581B2 (en) 2012-12-13 2016-07-05 Roche Molecular Systems, Inc. Primers with modified phosphate and base in allele-specific PCR
US9279146B2 (en) 2012-12-21 2016-03-08 Roche Molecular Systems, Inc. Compounds and methods for the enrichment of mutated nucleic acid from a mixture
UY35468A (en) 2013-03-16 2014-10-31 Novartis Ag CANCER TREATMENT USING AN ANTI-CD19 CHEMERIC ANTIGEN RECEIVER
CA2912059A1 (en) 2013-05-10 2014-11-13 Foundation Medicine, Inc. Analysis of genetic variants
US9873908B2 (en) 2013-11-27 2018-01-23 Roche Molecular Systems, Inc. Methods for the enrichment of mutated nucleic acid from a mixture
DK3083994T3 (en) 2013-12-20 2021-09-13 Illumina Inc Preservation of genomic connectivity information in fragmented genomic DNA samples
US9944924B2 (en) 2014-01-16 2018-04-17 Illumina, Inc. Polynucleotide modification on solid support
AU2015210886A1 (en) 2014-01-29 2016-09-01 Caris Mpi, Inc. Molecular profiling of immune modulators
US9670530B2 (en) 2014-01-30 2017-06-06 Illumina, Inc. Haplotype resolved genome sequencing
US10160998B2 (en) 2014-02-07 2018-12-25 Qiagen Sciences, Llc PCR primers containing cleavable nucleotides
JP6664332B2 (en) 2014-03-18 2020-03-13 キアゲン ゲーエムベーハー Stabilization and isolation of extracellular nucleic acids
CN106462669A (en) 2014-03-25 2017-02-22 奎斯特诊断投资股份有限公司 Detection of gene fusions by intragenic differential expression (ide) using average cycle thresholds
WO2015173222A1 (en) 2014-05-12 2015-11-19 Roche Diagnostics Gmbh Rare variant calls in ultra-deep sequencing
CA2950298A1 (en) 2014-06-03 2015-12-10 Illumina, Inc. Compositions, systems, and methods for detecting events using tethers anchored to or adjacent to nanopores
GB201410646D0 (en) 2014-06-14 2014-07-30 Illumina Cambridge Ltd Methods of increasing sequencing accuracy
US10017759B2 (en) 2014-06-26 2018-07-10 Illumina, Inc. Library preparation of tagged nucleic acid
WO2015198074A1 (en) 2014-06-27 2015-12-30 Illumina Cambridge Limited Methods, applications and systems for processing and presenting gene sequencing information
WO2016010856A1 (en) 2014-07-15 2016-01-21 Qiagen Sciences, Llc Semi-random barcodes for nucleic acid analysis
US10658073B2 (en) 2014-08-15 2020-05-19 QIAGEN Redwood City, Inc. Methods and systems for interpretation and reporting of sequence-based genetic tests using pooled allele statistics
ES2803079T3 (en) 2014-09-12 2021-01-22 Illumina Inc Methods to detect the presence of polymer subunits using chemiluminescence
EP3218511B1 (en) 2014-11-11 2020-04-22 Illumina Cambridge Limited Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid
JP6905934B2 (en) 2014-12-05 2021-07-21 ファウンデーション・メディシン・インコーポレイテッド Multiple gene analysis of tumor samples
EP3234187B1 (en) 2014-12-15 2021-02-17 Illumina, Inc. Method for single molecular placement on a substrate
US10792299B2 (en) 2014-12-26 2020-10-06 Nitto Denko Corporation Methods and compositions for treating malignant tumors associated with kras mutation
ES2828279T3 (en) 2014-12-31 2021-05-25 Guardant Health Inc Detection and treatment of diseases showing cellular heterogeneity of disease and systems and methods for communicating test results
EP3763825A1 (en) 2015-01-23 2021-01-13 Qiagen Sciences, LLC High multiplex pcr with molecular barcoding
KR20200020997A (en) 2015-02-10 2020-02-26 일루미나, 인코포레이티드 The method and the composition for analyzing the cellular constituent
WO2016135300A1 (en) 2015-02-26 2016-09-01 Qiagen Gmbh Efficiency improving methods for gene library generation
CA2978628A1 (en) * 2015-03-03 2016-09-09 Caris Mpi, Inc. Molecular profiling for cancer
CA2980327A1 (en) 2015-03-26 2016-09-29 Quest Diagnostics Investments Incorporated Alignment and variant sequencing analysis pipeline
US9828672B2 (en) 2015-03-26 2017-11-28 Lam Research Corporation Minimizing radical recombination using ALD silicon oxide surface coating with intermittent restoration plasma
EP3277837A1 (en) 2015-03-31 2018-02-07 Qiagen GmbH Efficiency improving ligation methods
WO2016170147A1 (en) 2015-04-22 2016-10-27 Qiagen Gmbh Efficiency improving ligation methods
US10844428B2 (en) 2015-04-28 2020-11-24 Illumina, Inc. Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS)
WO2016179049A1 (en) 2015-05-01 2016-11-10 Guardant Health, Inc Diagnostic methods
US10689710B2 (en) 2015-05-27 2020-06-23 Quest Diagnostics Investments Incorporated Methods for screening solid tumors for mutations
CA2986074A1 (en) 2015-06-03 2016-12-08 Illumina, Inc. Compositions, systems, and methods for sequencing polynucleotides using tethers anchored to polymerases adjacent to nanopores
WO2016193490A1 (en) 2015-06-05 2016-12-08 Qiagen Gmbh Method for separating dna by size
WO2016198571A1 (en) 2015-06-10 2016-12-15 Qiagen Gmbh Method for isolating extracellular nucleic acids using anion exchange particles
WO2017004243A1 (en) 2015-06-29 2017-01-05 Caris Science, Inc. Therapeutic oligonucleotides
DK3320111T3 (en) 2015-07-06 2021-07-19 Illumina Cambridge Ltd Sample preparation for nucleic acid amplification
US10640823B2 (en) 2015-07-08 2020-05-05 Quest Diagnostics Investments Incorporated Detecting genetic copy number variation
JP2018524014A (en) 2015-07-21 2018-08-30 ガーダント ヘルス, インコーポレイテッド Locked nucleic acid to capture fusion genes
US10913975B2 (en) 2015-07-27 2021-02-09 Illumina, Inc. Spatial mapping of nucleic acid sequence information
AU2016313095A1 (en) 2015-08-24 2017-11-23 Qiagen Gmbh Method for generating a RNA-sequencing library
US20170058332A1 (en) 2015-09-02 2017-03-02 Guardant Health, Inc. Identification of somatic mutations versus germline variants for cell-free dna variant calling applications
US20170061072A1 (en) 2015-09-02 2017-03-02 Guardant Health, Inc. Machine Learning for Somatic Single Nucleotide Variant Detection in Cell-free Tumor Nucleic acid Sequencing Applications
WO2017053915A1 (en) 2015-09-24 2017-03-30 Caris Science, Inc. Method, apparatus, and computer program product for analyzing biological data
US10577643B2 (en) 2015-10-07 2020-03-03 Illumina, Inc. Off-target capture reduction in sequencing techniques
EP3693459A1 (en) 2015-10-10 2020-08-12 Guardant Health, Inc. Methods and applications of gene fusion detection in cell-free dna analysis
WO2017085321A1 (en) 2015-11-20 2017-05-26 Qiagen Gmbh Method of preparing sterilized compositions for stabilization of extracellular nucleic acids
SG11201805119QA (en) 2015-12-17 2018-07-30 Guardant Health Inc Methods to determine tumor gene copy number by analysis of cell-free dna
CA3011342A1 (en) 2016-01-15 2017-07-20 Ventana Medical Systems, Inc. Deep sequencing profiling of tumors
WO2017127741A1 (en) 2016-01-22 2017-07-27 Grail, Inc. Methods and systems for high fidelity sequencing
JP6876062B2 (en) 2016-01-26 2021-05-26 ヴェンタナ メディカル システムズ, インク. Predictive diagnostic workflow for tumors with automated disection, next-generation sequencing, and automated slide staining equipment
WO2017132438A1 (en) 2016-01-29 2017-08-03 The Johns Hopkins University Bottleneck sequencing
CN109072309A (en) 2016-02-02 2018-12-21 夸登特健康公司 Cancer evolution detection and diagnosis
CN109196359A (en) 2016-02-29 2019-01-11 基础医疗股份有限公司 For assessing the method and system of Tumor mutations load
WO2017181146A1 (en) 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
EP3443118A2 (en) 2016-04-15 2019-02-20 H. Hoffnabb-La Roche Ag Detecting cancer driver genes and pathways
US20170316149A1 (en) 2016-04-28 2017-11-02 Quest Diagnostics Investments Inc. Classification of genetic variants
US20190136303A1 (en) 2016-05-11 2019-05-09 Illumina, Inc. Polynucleotide enrichment and amplification using crispr-cas or argonaute systems
EP3458597A4 (en) 2016-05-18 2020-01-15 Roche Diagnostics GmbH Quantitative real time pcr amplification using an electrowetting-based device
EP3464597A4 (en) 2016-05-25 2020-03-18 Caris Science, Inc. Oligonucleotide probes and uses thereof
WO2017218512A1 (en) 2016-06-13 2017-12-21 Grail, Inc. Enrichment of mutated cell free nucleic acids for cancer detection
EP3478856B1 (en) 2016-06-30 2021-01-27 Grail, Inc. Differential tagging of rna for preparation of a cell-free dna/rna sequencing library
KR20190026837A (en) 2016-07-06 2019-03-13 가던트 헬쓰, 인크. Methods for fragmentation profiling of cell-free nucleic acids
WO2018013598A1 (en) 2016-07-12 2018-01-18 Qiagen Sciences, Llc Single end duplex dna sequencing
WO2018018008A1 (en) 2016-07-22 2018-01-25 Oregon Health & Science University Single cell whole genome libraries and combinatorial indexing methods of making thereof
CA3037917A1 (en) 2016-09-22 2018-03-29 Illumina, Inc. Somatic copy number variation detection
EP3299471B1 (en) 2016-09-23 2019-10-23 Roche Diagniostics GmbH Methods for determining the amount of a nucleic acid of interest in an unprocessed sample
US10487358B2 (en) 2016-09-23 2019-11-26 Grail, Inc. Methods of preparing and analyzing cell-free nucleic acid sequencing libraries
WO2018064229A1 (en) 2016-09-27 2018-04-05 Caris Science, Inc. Oligonucleotide probes and uses thereof
ES2840003T3 (en) 2016-09-30 2021-07-06 Guardant Health Inc Methods for multi-resolution analysis of cell-free nucleic acids
US10810213B2 (en) 2016-10-03 2020-10-20 Illumina, Inc. Phenotype/disease specific gene ranking using curated, gene library and network based data structures
KR20190017825A (en) 2016-10-07 2019-02-20 일루미나, 인코포레이티드 System and method for secondary analysis of nucleotide sequence analysis data
CN110291212A (en) 2017-01-25 2019-09-27 香港中文大学 Use the diagnostic application of nucleic acid fragment
CN110100013A (en) 2016-10-24 2019-08-06 香港中文大学 Method and system for lesion detection
WO2018081604A1 (en) 2016-10-28 2018-05-03 Grail, Inc. Methods for single-stranded nucleic acid library preparation
WO2018077847A1 (en) 2016-10-31 2018-05-03 F. Hoffmann-La Roche Ag Barcoded circular library construction for identification of chimeric products
CN109906276A (en) 2016-11-07 2019-06-18 格里尔公司 For detecting the recognition methods of somatic mutation feature in early-stage cancer
US20190348149A1 (en) 2016-11-16 2019-11-14 Illumina, Inc. Validation methods and systems for sequence variant calls
WO2018111872A1 (en) 2016-12-12 2018-06-21 Grail, Inc. Methods for tagging and amplifying rna template molecules for preparing sequencing libraries
WO2018119438A1 (en) 2016-12-22 2018-06-28 Grail, Inc. Base coverage normalization and use thereof in detecting copy number variation
MX2019007444A (en) 2016-12-22 2019-08-16 Guardant Health Inc Methods and systems for analyzing nucleic acid molecules.
WO2018119399A1 (en) 2016-12-23 2018-06-28 Grail, Inc. Methods for high efficiency library preparation using double-stranded adapters
MX2019007894A (en) 2016-12-28 2019-12-11 Quest Diagnostics Invest Llc Compositions and methods for detecting circulating tumor dna.
US20200090784A1 (en) 2017-01-17 2020-03-19 Illumina, Inc. Oncogenic splice variant determination
KR20190117529A (en) 2017-01-18 2019-10-16 일루미나, 인코포레이티드 Method and system for generation and error correction of unique molecular index sets with heterogeneous molecular length
WO2018137826A1 (en) 2017-01-26 2018-08-02 Qiagen Gmbh Method for enriching template nucleic acids
CA3064765A1 (en) 2017-05-26 2018-11-29 Novelis Inc. Fluid temperature control system and method for decoating kiln
CA3072195A1 (en) * 2017-08-07 2019-04-04 The Johns Hopkins University Methods and materials for assessing and treating cancer

Also Published As

Publication number Publication date
AU2018342007A1 (en) 2020-02-27
CA3072195A1 (en) 2019-04-04
BR112020002555A2 (en) 2020-08-11
CL2020000343A1 (en) 2021-03-19
US20190256924A1 (en) 2019-08-22
US20200377956A1 (en) 2020-12-03
EP3665308A1 (en) 2020-06-17
JP2020530290A (en) 2020-10-22
EP3837385A1 (en) 2021-06-23
WO2019067092A1 (en) 2019-04-04
IL272470D0 (en) 2020-03-31
KR20200115450A (en) 2020-10-07
CN111868260A (en) 2020-10-30
WO2020150656A1 (en) 2020-07-23

Similar Documents

Publication Publication Date Title
SG11202001010UA (en) Methods and materials for assessing and treating cancer
HK1253093A1 (en) Methods of diagnosing and treating cancer
IL263224D0 (en) Methods and compositions for treating cancers
IL262225D0 (en) Methods for monitoring and treating cancer
IL269150D0 (en) Compositions and methods for treating cancer
IL266053D0 (en) Compositions and methods for treating ezh2-mediated cancer
IL268985D0 (en) Method for assessing and treating cellulite
HK1251862A1 (en) Methods and compositons for treating cancer
HRP20210133T1 (en) Combining adenovirus and checkpoint inhibitors for treating cancer
EP3714043A4 (en) Compositions and methods for treating cancer
EP3697767A4 (en) Compounds and methods for treating cancer
EP3119427A4 (en) Methods and materials for treating cancer
IL269157D0 (en) Compositions and methods for treating cancer
IL262223D0 (en) Methods for monitoring and treating cancer
ZA201802618B (en) Anti-cd43 antibody and use thereof for cancer treatment
EP3119426A4 (en) Methods and materials for treating cancer
EP3519592A4 (en) Materials and methods for evaluating and treating cancer
SG10202013112YA (en) Zinc-gamma-pga compositions and methods for treating cancer
EP3271483A4 (en) Methods and materials for assessing and treating cancer
EP3273970A4 (en) Methods and materials for treating cancer
EP3258923A4 (en) Methods and materials for assessing chemotherapy responsiveness and treating cancer
EP3709999A4 (en) Compositions and methods for treating cancer
EP3568145A4 (en) Materials and methods for treating cancer
IL255541D0 (en) Cabazitaxel and its use for treating cancer
EP3255994A4 (en) Methods and materials for assessing and treating arthritis